| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |